148 related articles for article (PubMed ID: 38190238)
21. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
22. Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
Heydari R; Fayazzadeh S; Shahrokh S; Shekari F; Farsad F; Meyfour A
Inflamm Bowel Dis; 2024 May; 30(5):795-807. PubMed ID: 37855715
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
[TBL] [Abstract][Full Text] [Related]
24. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
25. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting.
Sarrabayrouse G; Elias A; Yáñez F; Mayorga L; Varela E; Bartoli C; Casellas F; Borruel N; Herrera de Guise C; Machiels K; Vermeire S; Manichanh C
mSystems; 2021 Mar; 6(2):. PubMed ID: 33758031
[TBL] [Abstract][Full Text] [Related]
26. Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease.
Kalla R; Adams AT; Ventham NT; Kennedy NA; White R; Clarke C; Ivens A; Bergemalm D; Vatn S; Lopez-Jimena B; ; Ricanek P; Vatn MH; Söderholm JD; Gomollón F; Nowak JK; Jahnsen J; Halfvarson J; McTaggart S; Ho GT; Buck A; Satsangi J
J Crohns Colitis; 2020 Dec; 14(12):1724-1733. PubMed ID: 32598439
[TBL] [Abstract][Full Text] [Related]
27. Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations - a cohort study in Bulgarian patients.
Atanassova A; Georgieva A
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6310-6315. PubMed ID: 36111932
[TBL] [Abstract][Full Text] [Related]
28. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
[TBL] [Abstract][Full Text] [Related]
29. Function of intestinal barrier protected by regulating the miR-199a-3p in ulcerative colitis: Modulation of IL-23/IL-17A axis.
Zhang H; Zhang F; Li W
Fundam Clin Pharmacol; 2021 Oct; 35(5):852-860. PubMed ID: 33475196
[TBL] [Abstract][Full Text] [Related]
30. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
Front Immunol; 2022; 13():921546. PubMed ID: 35860271
[TBL] [Abstract][Full Text] [Related]
31. Amino acids-targeted metabolomics reveals novel diagnostic biomarkers for ulcerative colitis and Crohn's disease.
Zhou G; Liu H; Wei P; He Q; Zhang J; Shi Q; Liu T; Liu S
Amino Acids; 2023 Mar; 55(3):349-358. PubMed ID: 36625991
[TBL] [Abstract][Full Text] [Related]
32. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
33. Soluble ST2: a new and promising activity marker in ulcerative colitis.
Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
[TBL] [Abstract][Full Text] [Related]
34. Serum Visfatin as a Diagnostic Marker of Active Inflammatory Bowel Disease.
Saadoun MM; Nosair NAE; Abdel-Azeez HA; Sharaf SM; Ahmed MH
J Gastrointestin Liver Dis; 2021 Sep; 30(3):339-345. PubMed ID: 34551033
[TBL] [Abstract][Full Text] [Related]
35. Serological profiling of Crohn's disease and ulcerative colitis patients reveals anti-microbial antibody signatures.
Shome M; Song L; Williams S; Chung Y; Murugan V; Park JG; Faubion W; Pasha SF; Leighton JA; LaBaer J; Qiu J
World J Gastroenterol; 2022 Aug; 28(30):4089-4101. PubMed ID: 36157118
[TBL] [Abstract][Full Text] [Related]
36. lncRNA ANRIL Ameliorates Oxygen and Glucose Deprivation (OGD) Induced Injury in Neuron Cells via miR-199a-5p/CAV-1 Axis.
Zhong W; Li YC; Huang QY; Tang XQ
Neurochem Res; 2020 Apr; 45(4):772-782. PubMed ID: 31907708
[TBL] [Abstract][Full Text] [Related]
37. Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease.
Wang H; Zhang S; Yu Q; Yang G; Guo J; Li M; Zeng Z; He Y; Chen B; Chen M
Medicine (Baltimore); 2016 Feb; 95(5):e2703. PubMed ID: 26844512
[TBL] [Abstract][Full Text] [Related]
38. FACTORS ASSOCIATED WITH CIRCULATING ZONULIN IN INFLAMMATORY BOWEL DISEASE.
Lacombe LAC; Matiollo C; Rosa JSD; Felisberto M; Dalmarco EM; Schiavon LL
Arq Gastroenterol; 2022; 59(2):238-243. PubMed ID: 35830035
[TBL] [Abstract][Full Text] [Related]
39. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
[TBL] [Abstract][Full Text] [Related]
40. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
